Using biomarkers to detect the pathology of Alzheimer’s disease

How can biomarkers be used to examine the pathology of Alzheimer’s disease (AD) patients? Melissa Murray, PhD from the Mayo Clinic, Jacksonville, FL talks to us about work focusing on the use of tau imaging to detect disease pathology, which was presented at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK. Dr Murray also speaks about an upcoming session related to biomarkers, and tells us what this research could mean for AD patients.

Share this video